| Organism name | Papaver somniferum L. |
|---|---|
| Genus | Papaver |
| Family | Papaveraceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Papaver somniferum |
|---|---|
| Linked NCBI taxonomy ID | 3469 |
| Linked level | species |
| Family in NCBI taxonomy | Papaveraceae |
|---|---|
| ID | 3465 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | eudicotyledons |
|---|---|
| ID | 71240 |
| Species | Activity |
|---|---|
| Papaver somniferum L. | Abortifacient |
| Papaver somniferum L. | Analgesic |
| Papaver somniferum L. | Anaphrodisiac |
| Papaver somniferum L. | Antibacterial |
| Papaver somniferum L. | Antidiarrheal |
| Papaver somniferum L. | Antidote, atropine |
| Papaver somniferum L. | Antidote, physostigmine |
| Papaver somniferum L. | Antidote, strychnine |
| Papaver somniferum L. | Antiinflammatory |
| Papaver somniferum L. | Antipyretic |
| Papaver somniferum L. | Antispasmodic |
| Papaver somniferum L. | Antitussive |
| Papaver somniferum L. | Aphrodisiac |
| Papaver somniferum L. | Astringent |
| Papaver somniferum L. | Calmative |
| Papaver somniferum L. | Carminative |
| Papaver somniferum L. | Cerebrostimulant |
| Papaver somniferum L. | Decongestant |
| Papaver somniferum L. | Deliriant |
| Papaver somniferum L. | Demulcent |
| Papaver somniferum L. | Diaphoretic |
| Papaver somniferum L. | Diuretic |
| Papaver somniferum L. | Duphoric |
| Papaver somniferum L. | Emollient |
| Papaver somniferum L. | Expectorant |
| Papaver somniferum L. | Hemostat |
| Papaver somniferum L. | Hypnotic |
| Papaver somniferum L. | Hypotensive |
| Papaver somniferum L. | Intoxicant |
| Papaver somniferum L. | Lipogenic |
| Papaver somniferum L. | Myorelaxant |
| Papaver somniferum L. | Narcotic |
| Papaver somniferum L. | Nervine |
| Papaver somniferum L. | Sedative |
| Papaver somniferum L. | Spinostimulant |
| Papaver somniferum L. | Stimulant |
| Papaver somniferum L. | Tonic |
| Papaver somniferum L. | Tranquilizer |
| Papaver somniferum L. | Vasodilator |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00026092
|
Scoulerine
/ (-)-Scoulerine |
CHEMBL191133
CHEMBL1235966 CHEMBL1395394 |
27 / 19 / 15 | No. 37 | No. 4 |
|
||
|
C00024626
|
6-Acetonyldihydrosanguinarine
/ 6-Acetonyl-5,6-dihydrosanguinarine |
No. 195 | No. 4 |
|
||||
|
C00024657
|
Norsanguinarine
/ N-Norsanguinarine / 13-Demethylsanguinarine |
No. 254 | No. 4 |
|
||||
|
C00025458
|
Papaverrubine B
/ O-Methylporphyroxine |
No. 305 |
|
|||||
|
C00025459
|
Papaverrubine C
/ Epiporphyroxine / 14-Epiporphyroxine |
No. 305 |
|
|||||
|
C00025452
|
Glaudine
|
No. 305 |
|
|||||
|
C00025461
|
Papaverrubine E
|
No. 305 |
|
|||||
|
C00025460
|
Porphyroxine
/ Papaverrubine D |
No. 305 |
|
|||||
|
C00025654
|
Codamine
/ (+)-Codamine / L-(+)-Codamine / (S)-(+)-Codamine |
CHEMBL251624
|
No. 345 | No. 4 |
|
|||
|
C00037598
|
Xanthaline
/ Papaveraldine |
CHEMBL205040
|
C039655
|
15 / 10 / 5 | No. 1165 | No. 4 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00026092 C00037598 | 0 / 0 |
| O14727 | Apoptotic protease-activating factor 1 | Unclassified protein | C00026092 C00037598 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00026092 C00037598 | 1 / 1 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00026092 C00037598 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00026092 C00037598 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00026092 C00037598 | 1 / 1 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00026092 C00037598 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00026092 | 1 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00026092 | 0 / 1 |
| Q9BQF6 | Sentrin-specific protease 7 | Enzyme | C00037598 | 0 / 0 |
| Q9GZR1 | Sentrin-specific protease 6 | Enzyme | C00037598 | 0 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00026092 | 2 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00026092 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00026092 | 0 / 0 |
| Q96LD8 | Sentrin-specific protease 8 | Enzyme | C00037598 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00037598 | 7 / 3 |
| P02545 | Prelamin-A/C | Unclassified protein | C00026092 | 11 / 10 |
| P42574 | Caspase-3 | C14 | C00037598 | 0 / 0 |
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00026092 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00026092 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00026092 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00026092 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00037598 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00026092 | 0 / 0 |
| P62136 | Serine/threonine-protein phosphatase PP1-alpha catalytic subunit | Ser_Thr | C00037598 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00026092 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00026092 | 0 / 1 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00026092 | 0 / 0 |
| Q9BPW0 | Serine/threonine-protein phosphatase | Enzyme | C00037598 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00026092 | 0 / 0 |
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00026092 | 1 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00026092 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00026092 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00026092 | 1 / 0 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00026092 | 0 / 0 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #103780 | Alcohol dependence |
P14416
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|